Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
To invite people, share this page:
About This Webinar

This webinar aims for our experts to present and provide our listeners with a good understanding of Brexit's impact on EU and UK pharmacovigilance processes, highlighting the challenges for the Pharmaceutical Industry and the critical requirements that could arise.

  • PV Procedures
  • Submission
  • Registering to make submissions to MHRA
Language: English
Who can attend? Everyone
Featured Presenters
Webinar hosting presenter James Sarene
Managing Director & Founder
Webinar hosting presenter
PrimeVigilance, Senior Director, EU QPPV, UK QPPV
Marcela is a pharmacovigilance professional with more than 20 years of experience in the pharmaceutical business. She has spent the majority of this time in pharmacovigilance, as well as quality assurance, auditing and regulatory affairs.
Webinar hosting presenter
PrimeVigilance, Director, EU QPPV, UK QPPV
Jana is an expert in pharmacovigilance, with more than 15 years of experience at several global pharma companies. She has worked at PrimeVigilance since 2014, plus additionally serves as EU QPPV for several clients and conducts PV audits as requested by clients.
Webinar hosting presenter
PrimeVigilance, an Ergomed Group company, was established in 2008 by Dr. Miroslav Reljanovic together with co-founder Dr. Elliot Brown. PrimeVigilance offers holistic, top quality, cost-effective, innovative safety services for pharmaceutical, generic and biotechnology companies. Our founders and leaders have an unrivaled reputation in the sector with a network of expert associates across the world. These include former senior regulators and consultants with extensive industry experience, especially with marketed products.
Hosted By
BioAlliance Video Network webinar platform hosts The Impact of Brexit on Pharmacovigilance
BioAlliance Video Network's Webinars and Video Conferences